Renesmee Kuo
Ph.D. Student in Electrical Engineering, admitted Autumn 2022
Bio
Renesmee Kuo is an Electrical Engineering PhD candidate at Stanford University supported by NSF GRFP. Her research interests lie at the intersection of engineering and medicine. She focuses on validation of preclinical PET imaging tracers and their translation into the clinic for applications in neuroinflammatory diseases (e.g., MS, AD) and cancer (e.g., brain metastasis) in Prof. Michelle James' lab. She graduated from UC Berkeley with a BS in Bioengineering. At Berkeley, she worked in Prof. Steve Conolly's lab on Magnetic Particle Imaging (MPI), focusing on tracking CAR-T cells in immunotherapy using high-resolution MPI tracers. She also explored commercially-available high-resolution MPI tracers for early diagnosis of pulmonary embolisms and cardiovascular disease in preclinical settings.
Honors & Awards
-
1st place Young Investigator Award, World Molecular Imaging Congress (2024)
-
2nd place Young Investigator Award (Brain Imaging Council), Society of Nuclear Medicine and Molecular Imaging (SNMMI) (2024)
-
Graduate Research Fellowship, National Science Foundation (2022)
-
Electrical Engineering Department Fellowship, Stanford University (2022)
-
Young Investigator Award, American Association of Physicists in Medicine (2022)
-
Jacobs Institute Innovation Catalysts Ignite Grant, University of California, Berkeley (2021)
Education & Certifications
-
MS, Stanford University, Electrical Engineering (2024)
-
BS, University of California, Berkeley, Bioengineering (2022)
All Publications
-
Early detection and tracking of activated macrophages and microglia in a mouse model of multiple sclerosis using [18F]OP-801 PET imaging before and after a novel immunomodulatory drug
SOC NUCLEAR MEDICINE INC. 2024
View details for Web of Science ID 001289165603246
-
Illuminating pro-inflammatory myeloid cells in a murine model of multiple sclerosis using a new 18F-labeled GPR84-targeted radiotracer
SOC NUCLEAR MEDICINE INC. 2024
View details for Web of Science ID 001289165603162
-
Development and comparison of two novel PET tracers for imaging proinflammatory receptor GPR84 in human cells and tissues
SOC NUCLEAR MEDICINE INC. 2024
View details for Web of Science ID 001289165602056
-
PET Imaging of Innate Immune Activation Using 11C Radiotracers Targeting GPR84.
JACS Au
2023; 3 (12): 3297-3310
Abstract
Chronic innate immune activation is a key hallmark of many neurological diseases and is known to result in the upregulation of GPR84 in myeloid cells (macrophages, microglia, and monocytes). As such, GPR84 can potentially serve as a sensor of proinflammatory innate immune responses. To assess the utility of GPR84 as an imaging biomarker, we synthesized 11C-MGX-10S and 11C-MGX-11Svia carbon-11 alkylation for use as positron emission tomography (PET) tracers targeting this receptor. In vitro experiments demonstrated significantly higher binding of both radiotracers to hGPR84-HEK293 cells than that of parental control HEK293 cells. Co-incubation with the GPR84 antagonist GLPG1205 reduced the binding of both radiotracers by >90%, demonstrating their high specificity for GPR84 in vitro. In vivo assessment of each radiotracer via PET imaging of healthy mice illustrated the superior brain uptake and pharmacokinetics of 11C-MGX-10S compared to 11C-MGX-11S. Subsequent use of 11C-MGX-10S to image a well-established mouse model of systemic and neuro-inflammation revealed a high PET signal in affected tissues, including the brain, liver, lung, and spleen. In vivo specificity of 11C-MGX-10S for GPR84 was confirmed by the administration of GLPG1205 followed by radiotracer injection. When compared with 11C-DPA-713-an existing radiotracer used to image innate immune activation in clinical research studies-11C-MGX-10S has multiple advantages, including its higher binding signal in inflamed tissues in the CNS and periphery and low background signal in healthy saline-treated subjects. The pronounced uptake of 11C-MGX-10S during inflammation, its high specificity for GPR84, and suitable pharmacokinetics strongly support further investigation of 11C-MGX-10S for imaging GPR84-positive myeloid cells associated with innate immune activation in animal models of inflammatory diseases and human neuropathology.
View details for DOI 10.1021/jacsau.3c00435
View details for PubMedID 38155640
View details for PubMedCentralID PMC10751761
-
Application of Machine Learning Driven Computational Approaches for Novel CNS PET Tracer Development
ELSEVIER SCIENCE INC. 2023: S40-S41
View details for Web of Science ID 001128725600053
-
Magnetic Particle Imaging in Vascular Imaging, Immunotherapy, Cell Tracking, and Noninvasive Diagnosis
MOLECULAR IMAGING
2023; 2023
View details for DOI 10.1155/2023/4131117
View details for Web of Science ID 000956804400001